Efficacy and safety of 24 weeks treatment with oral TLR8 agonist, selgantolimod, in virally-suppressed adult patients with chronic hepatitis B: a phase 2 study

Edward Gane, P. Rod Dunbar, Anna E. S. Brooks, Yang Zhao, Susanna K. Tan, Audrey Lau, Jenny Yang, Anuj Gaggar, Mani Subramanian, Shyamasundaran Kottilil, Lydia Tang